Range Cancer Therapeutics Etf (CNCR) Technical Analysis

$13.66▲-2.15%

Market is closed - opens 8 PM, 06 Dec 2024

Insights

Range Cancer Therapeutics Etf is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Based on analysis of the Oscillators technical indicator, the current market trend for Range Cancer Therapeutics Etf stock suggests that it is range bound and no decision can be made based on this information
Based on analysis of the Moving Averages technical indicator, Range Cancer Therapeutics Etf stock is in a downtrend↘️
Based on analysis of the Pivot Points, the current market trend for Range Cancer Therapeutics Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name	Value	Action
Relative Strength Index	50.37	Neutral
Stochastic	52.87, 45.17	Neutral
Ultimate Oscillator	57.54	Neutral
Stochastic Relative Strength Index	73.7, 55.66	Neutral
Moving Average Convergence Divergence	-0.25, -0.3	Neutral

Moving Averages

Simple Moving Average

Period (Days)	Value	Action
10	13.75	Sell
20	14.4	Sell
50	14.7	Sell

Exponential Moving Average

Period (Days)	Value	Action
10	14.07	Sell
20	14.25	Sell
50	14.54	Buy

Volume Weighted Moving Average

Period (Days)	Value	Action
10	13.62	Neutral
20	14.34	Neutral
50	14.72	Sell

Double Exponential Moving Average

Period (Days)	Value	Action
10	13.99	Buy
20	13.9	Sell
50	14.37	Sell

Triple Exponential Moving Average

Period (Days)	Value	Action
10	14.2	Buy
20	13.8	Sell
50	14.02	Sell

Pivot

Pivot	Value
Resistance L3	14.51
Resistance L2	14.43
Resistance L1	14.39
Pivot Point	14.31
Support L1	14.27
Support L2	14.19
Support L3	14.15

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.